A questionnaire for neurological symptoms in patients with diabetes - Cross-sectional multicenter study in Saitama Prefecture, Japan

Diabetes Research and Clinical Practice

Volumn 54, Issue 1, 2001, Pages 41-47

  Kawano, Mikihiko ^a   Omori, Yasue ^b   Katayama, Shigehiro ^c   Kawakami, Masanobu ^a   Suzuki, Yutaka ^d   Takahashi, Kiyoko ^e   Takemura, Yoshihiro ^f   Nagata, Naokazu ^g   Hiratsuka, Atsushi ^h   Matsuzaki, Fukashi ⁱ   Kanazawa, Yasunori ^a   Akanuma, Yasuo ^j  

^a JICHI MEDICAL UNIVERSITY   (Japan)

^b Saiseikai Kurihashi Hospital   (Japan)

^c SAITAMA MEDICAL UNIVERSITY   (Japan)

^d SAITAMA SOCIAL INSURANCE HOSPITAL   (Japan)

^e Urawa Municipal Hospital   (Japan)

^f DOKKYO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^g NATIONAL DEFENSE MEDICAL COLLEGE   (Japan)

^h National Hospital Organization Nishisaitama Chuo National Hospital   (Japan)

ⁱ SAITAMA MEDICAL CENTER   (Japan)

^j INSTITUTE FOR ADULT DISEASES   (Japan)

more..

Author keywords

Cross sectional study; Diabetes mellitus; Multicenter study; Neuropathy; Questionnaire

Indexed keywords

ALDOSE REDUCTASE INHIBITOR; BIGUANIDE DERIVATIVE; HEMOGLOBIN A1C; INSULIN; SULFONYLUREA DERIVATIVE; TROGLITAZONE;

ACHILLES REFLEX; ADULT; AGED; ARTICLE; CLINICAL TRIAL; DIABETES MELLITUS; DIABETIC NEUROPATHY; DIABETIC RETINOPATHY; DIET; DISEASE CONTROL; DISEASE DURATION; FEMALE; FOOT DISEASE; GLUCOSE BLOOD LEVEL; HUMAN; JAPAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PAIN; PRESCRIPTION; PROTEINURIA; QUESTIONNAIRE; TREATMENT OUTCOME;

AGED; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DIABETIC NEUROPATHIES; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; JAPAN; MALE; MIDDLE AGED; NEUROLOGIC EXAMINATION; OUTPATIENTS; PREVALENCE; QUESTIONNAIRES; REFLEX; SKIN;

EID: 0034856532     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8227(01)00256-X     Document Type: Article

References (5)

1. Diabetes mellitus and its degenerative complications; a prospective study of 4400 patients observed between 1947 and 1973
2. Factors in the development of diabetic neuropathy: baseline analysis of neuropathy in the feasibility phase of the Diabetes Control and Complications Trial (DCCT)
3. A multicenter study of the prevalence of diabetic peripheral neuropathy in the United Kingdom hospital clinic population
4. Quantitative sensory testing, cardiovascular autonomic tests and nerve conduction studies in diabetic neuropathy
5. Epidemiological correlates of diabetic neuropathy: report from Pittsburgh Epidemiology of Diabetes Complications Study